![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 17, 2012 4:46:44 PM
That's what I would do based on what I know about the products. I don't see anything holding BIEL back except time at the FDA to arrive at the approvals or for Whelan to sell the company to a manufacturer of acetaminophen wanting to hedge their bets with a drug-free pain technology.
Also, I was interested to hear yesterday, in the Whelan interview, confirmation of what I read in the recent bone regeneration study that not only does ActiPatch deal with pain, but it also stimulates bone growth as well. Is that new? I had not heard Whelan speak before, but the guy seems to know his stuff. I think the study was done in Chicago?
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM